|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/08 | (2019.01) |
| A61K 38/08 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 38/10 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/08 | (2018.01) |
| (11) | Number of the document | 3527217 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17859632.6 |
| Date of filing the European patent application | 2017-10-11 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/BR2017/050313 |
| Date | 2017-10-11 |
| (87) | Number | WO 2018/068119 |
| Date | 2018-04-19 |
| (30) | Number | Date | Country code |
| 102016023848 | 2016-10-13 | BR |
| (72) |
REMER, Ricardo Amaral , BR
HEIMANN, Andrea Sterman , BR
|
| (73) |
Proteimax Biotecnologia Ltda ,
Av. Corifeu de Azevedo Marques 1425-Sala 6
Butantã, 05581001 São Paulo,
BR
Remer Consultores Assessoria Empresarial Ltda. , Rua Padre João Manuel 755 - 9ª andar, 01411-001 São Paulo, BR |
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING PVNFKFLSH OR PVNFKLLSH PEPTIDES FOR USE IN THE PREVENTION AND TREATMENT OF CONVULSIONS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING PVNFKFLSH OR PVNFKLLSH PEPTIDES FOR USE IN THE PREVENTION AND TREATMENT OF CONVULSIONS |